How to buy Relmada Therapeutics (RLMD) shares in the UK

Learn how to easily invest in Relmada Therapeutics shares.

Relmada Therapeutics Inc (RLMD) is a publicly traded biotechnology business based in the US. In the week up to 28 September Relmada Therapeutics shares surged 16.37% to a closing position of $34.77. Over the last 12 months, Relmada Therapeutics's share price has risen by 33.14% from $25.71. Relmada Therapeutics is listed on the NASDAQ and employs 10 staff. All prices are listed in US Dollars.

How to buy shares in Relmada Therapeutics

  1. Choose a platform. If you're a beginner, our share-dealing table below can help you choose.
  2. Open your account. You'll need your ID, bank details and national insurance number.
  3. Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
  4. Search the platform for stock code: RLMD in this case.
  5. Research Relmada Therapeutics shares. The platform should provide the latest information available.
  6. Buy your Relmada Therapeutics shares. It's that simple.
The whole process can take as little as 15 minutes. You'll need a smartphone or computer, an internet connection, your passport or driving licence and a means of payment.

Fees for buying 20x Relmada Therapeutics shares with popular platforms

Both exchange rates and share prices fluctuate in real time, so the costs presented here should be considered as a guide only. They do not incorporate stamp duty. Always refer to the platform itself for availability and pricing – which may differ from our information.

Platform Platform fee Min. initial deposit Trading fee estimate
eToro Free Stocks logo £0 $10 £3.07
£616.54 total
Capital at risk
IG Share Dealing logo £0 £250 £12.07
£625.54 total
Capital at risk
Fineco logo £0 No minimum £6.13
£619.60 total
Capital at risk
Hargreaves Lansdown Fund and Share Account logo £0 £1 £18.08
£631.55 total
Capital at risk
Degiro Share Dealing logo £0 £0.01 £0.61
£614.08 total
Capital at risk
interactive investor Trading Account logo £9.99 per month No minimum £17.19
£630.66 total
Capital at risk
Stake logo £0 £50 £3.07
£616.54 total
Capital at risk
Halifax Share Dealing Account logo £36 per year £20 £17.17
£630.64 total
Capital at risk

Full comparison of share dealing platforms

Relmada Therapeutics share price (NASDAQ:RLMD)

Use our graph to track the performance of RLMD stocks over time.

Relmada Therapeutics price performance over time

Historical closes compared with the last close of $34.23

1 week (2022-09-22) 12.08%
1 month (2022-08-29) 12.64%
3 months (2022-06-29) 76.99%
6 months (2022-03-25) 32.93%
1 year (2021-09-29) 33.14%
2 years (2020-09-29) -8.50%
3 years (2019-09-27) 229.13%
5 years (2017-09-29) 800.79%

Is it a good time to buy Relmada Therapeutics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page.

Promoted
eToro Free Stocks

Invest in Relmada Therapeutics shares with 0% commission

  • Start investing from as little as $10
  • Pay no stamp duty on UK shares
  • Join 25 million users who trust their investments with eToro
Other fees apply. Capital at risk

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.

Relmada Therapeutics shares at a glance

Information last updated 2021-07-09.
Open$32.45
High$34.4
Low$32.25
Close$34.23
Previous close$32.29
Change$1.94
Change %6.0081%
Volume92,810
Information last updated 2022-09-25.
52-week range$15.735 - $34.53
50-day moving average$28.4878
200-day moving average$22.9106
Wall St. target price$61.43
Dividend yield$0 (0%)
Earnings per share (TTM)$-6.987

Do Relmada Therapeutics shares pay dividends?

We're not expecting Relmada Therapeutics to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.

Share price volatility

Over the last 12 months, Relmada Therapeutics's shares have ranged in value from as little as $15.735 up to $34.53. A popular way to gauge a stock's volatility is its "beta".

RLMD.US volatility(beta: 0.63)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Relmada Therapeutics's is 0.6256. This would suggest that Relmada Therapeutics's shares are less volatile than average (for this exchange).

Frequently asked questions

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site